Notice_of_Intent_to_SS__1195754.pdf

February 8, 2018 Notice of Intent to Sole Source for On‐site Parking Services with Option Years

FDA_SS_1195754

The Food and Drug Administration (FDA) intends to award a Sole Source firm‐fixed price purchase order to NGP‐V PARKLAWN MD, LLC located at 1650 Tysons Boulevard, Suite 200, McLean, VA 22102. In accordance with FAR part 6.302‐1, the contractor is the only responsible source who can provide the required services as no other source has been identified who can provide the on‐site parking services to satisfy the agencies requirements.

The purpose of this notice is to inform the public that FDA anticipates issuing an award for on‐site parking services to NGP‐V PARKLAWN MD, LLC for a Base Year and four (1) year maintenance option years:

The associated North American Industrial Classification System (NAICS) Code is 812930: Parking Lots and Garages.

TECHNICAL REQUIREMENTS:

A. Provide One Hundred ninety‐seven (197) Parking Permits for parking spaces located at 5630

Fishers Lane, Rockville, MD 20857 to accommodate FDA employees during business hours

(Monday‐Friday between 6:00 AM and 7:00 PM EST).

Employees shall have the ability to access the parking spaces after hours and weekends with valid key card.

B. Provide proper signage in accordance with County regulations that include times of operations, specially designated spaces (i.e., visitors, handicapped, carpool, and other spaces‐Directors, Managers, etc.).

C. Provide general maintenance to parking spaces, ramps and sidewalks during inclement weather (i.e., snow, ice and other debris).

D. Provide daily clean‐up, re‐paving, steam cleaning, leaf removal, restriping, damage repair/removal (i.e., pothole repair, structural repair, broken pavement, damaged lighting, etc.) as needed.

E. Ensure proper lighting and maintenance in parking areas in accordance with GSA Lease #

GS‐11B‐02172.

F. Ensure parking spaces have visible painted lines and signage for safe navigation in parking lot.

G. Maintain standard operation of ingress/egress equipment in parking area and ensure a towing contract and visible signage is on‐site stating that illegally parked cars will be towed.

H. Access control system shall be specified by FDA.

1. Vendor shall provide the government rights to install their own access control system.

2. The government agrees to coordinate and get approval of the vendor prior to installation at the government cost.

3. System will be coordinated to function as part of the building access control system.

4. Access control licenses will be distributed by the FDA. In the alternative, the vendor can perform this work at an appropriate fee to be negotiated.

5. Maintenance costs associated with an access control system will be the responsibility of the government.

This notice is not a request for competitive proposals. However, any party that believes it is capable of meeting this requirement as stated herein may submit a written capability statement that clearly supports and demonstrates their ability to perform the requirement.

Capability statements must be received by the response date and time of this notice. Submissions will be reviewed to determine if they can meet the requirement. A determination by the

Government to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government.

It is anticipated that an award will be issued to NGP‐V PARKLAWN MD, LLC, within approximately ten (10) days after the date of this notice unless the Government determines that any other organization has the capability to meet this requirement.

Response Date: February 19, 2018 by 7:00AM Eastern Time. Please email responses to Nicole Craig at nicole.craig@fda.hhs.gov. No phone calls will be accepted.